1. Read the sector-ETF internals to time a momentum-reset entry
The repeatable method
- When a hot group whipsaws violently, don't guess the bottom off price — read the internals of its ETF: RSI (is it back to a neutral ~50 from overbought?), the average constituent's short-window rate-of-change (how deep was the flush?), and the count at fresh highs vs knocked off them.
- Treat a "cooled but bouncing" reading (RSI ~49, average 10-day change bottomed near −15%, zero new highs but green today) as a reset that hands sidelined buyers an entry — not a breakdown.
- Accept you won't nail the low; the point is that the risk/reward improves once the froth is out, so a name you liked higher is more ownable lower.
Here: Brown on the SMH — RSI back to 49, average semi's 10-day rate-of-change hit −15%, 0 fresh 52-wk highs but bouncing: "you finally got an opportunity." Santoli's caution — don't declare the unwind finished just because earnings hold.
Watch for
- Sector-ETF RSI resetting toward 50; a deep average rate-of-change trough; the count of constituents reclaiming their moving averages.
2. Price in the leveraged-single-stock-ETF distortion — and sell the premium it creates
The repeatable method
- Recognize a structural fact: a large pool of leveraged 2× single-stock ETFs turns a given dollar of assets into ~2.5× that in notional exposure, so daily rebalancing amplifies moves regardless of any fundamental view.
- Don't react to the amplified move — treat the wild ±7% swings as noise from holders "with no meaningful point of view."
- Monetize the volatility instead: the same flows inflate options premium, so sell calls against a name you own to get paid to wait (and lower your effective cost basis).
Here: Brown sizes the force at ~$200B assets ≈ $500B notional. Bryn sells MU Sept-70 calls for $7 (cost basis ~53) and NVDA calls into that elevated premium rather than chasing the tape.
Watch for
- Elevated single-stock implied vol / call premium on the popular momentum names; days where the derivative flow, not news, drives the move.
3. Stay true to your knitting — don't switch styles mid-rotation
The repeatable method
- In a fast, day-to-day rotation, the biggest error is abandoning the style you're good at (a momentum investor turning fundamental, or vice versa) to chase the group leading today.
- Anchor buys to your own discipline: if you're a fundamental buyer and the thesis is unchanged, a lower price is a better entry, not a reason to wait for a signal you can't define.
- Allow that styles can intersect — the same name can be a value stock and a momentum play at once — but let your framework, not the rotation, drive the decision.
Here: Lebenthal doubles MU at $60 on unchanged fundamentals ("how could you not, if you liked it higher?"); he and Snipe both note Micron is value and momentum simultaneously.
Watch for
- The urge to buy whatever's green today; a thesis still intact while the price is lower — your cue to add, not wait.
4. Buy best-in-breed on a rare valuation discount (relative-underperformance screen)
The repeatable method
- Screen dominant compounders for the rare window when the stock lags badly while the fundamentals improve — measured by underperformance vs its group and a multiple at a multi-year low.
- Confirm the business is still winning (market share, margins, free-cash-flow trajectory, earnings revisions still rising) so you're buying a discount, not a value trap.
- Buy the leader rather than the cheaper also-ran; you're paying up in quality, down in price.
Here: Link initiates NVDA ("never owned it") at 18× PE / 15× EBITDA — cheapest since 2019, underperformed the group ~72% over a year, yet 97% GPU share and FCF doubling to $206B. "Best-in-breed on sale… buy low, sell high."
Watch for
- A dominant name at a multi-year-low multiple with rising earnings revisions; underperformance vs peers as the entry trigger, not the deterrent.
5. In a CapEx super-cycle, ask where the value accrues — own the customer, not the spender
The repeatable method
- Frame the whole theme as one question: of all this capital being spent, where does the profit finally land?
- Downgrade the spenders — companies handing >100% of cash flow to CapEx get no valuation premium (the market discounts them like industrial conglomerates; they're in the building, not harvesting, phase).
- Favor the owner of the end-demand / customer relationship, who can layer the new capability on an installed base and collect fees without funding the build-out. Flag the "double-benefit" cases (spender that also owns the product).
Here: Brown's answer is AAPL — 2.5B devices as the consumer-AI gateway, not playing the CapEx game (AT&T/Verizon built the internet; Instagram captured the value). GOOGL is the "double benefit" (spends and owns Gemini); MSFT/ORCL are the murky spenders.
Watch for
- CapEx as a share of operating cash flow; the shrinking Mag-7-vs-493 premium; who owns the customer at the far end of the spend.
6. Answer "is it a buy?" by naming the holding period first
The repeatable method
- Refuse the buy/no-buy question until the time frame is specified — the same stock can be a "no" for one month and a clear "yes" for three-months-plus.
- For the longer horizon, sanity-check with valuation that already prices the pessimism: a PE below the market multiple and a favorable PEG (price/earnings-to-growth) means you're paid to wait out the CapEx-drought-to-free-cash-flow-reversal.
- Separate the manager's own turnover from the call — a short-term rebalance out of a name isn't a long-term bear case.
Here: Lebenthal — the Mag-7 "isn't for you" on a 1-month view but "for the most part buys" past 3 months (META/NVDA below the market multiple on PE and PEG). Rieder had merely rebalanced within the mega-caps — not a sell signal.
Watch for
- PE/PEG vs the market and the name's own history; the point where CapEx-heavy free cash flow inflects positive.
7. After an indiscriminate "apocalypse" selloff, stratify the group — real disruption vs "wrong place, wrong time"
The repeatable method
- When a whole sector is sold as a basket on a narrative (here, "AI kills software / cyber"), separate the names with a genuine business-model threat from those just caught in the ETF-level dumping.
- Look for the company that flips the narrative with data — proving the disruptor is actually a tailwind (more AI → more of what it sells) and backing it with hard metrics (ARR growth, record free cash flow, a rule-of-40 score).
- Own the proven winner through the fear; use the poster-child laggards as the contrast, not the buy.
Here: CRWD (+68% YTD, ARR $5.51B +24%, record FCF $468M = 34% of revenue, rule-of-40 = 59) is the "more AI = more cyber" winner Brown won't sell; SNOW/NOW also stratify up, while CRM/ADBE were the "SAS-apocalypse" poster children.
Watch for
- A company reframing the disruptor as a demand driver; rule-of-40, ARR growth and FCF margin separating winners from the sold-off basket.
8. The "best stock in the market" screen — sector waking up + intact long-term trend + still-cheap-for-growth
The repeatable method
- Require the sector to be turning in your favor (financials waking up ahead of earnings) as the tailwind.
- Prefer a genuine turnaround with self-help catalysts still ahead (spin-offs, exiting regulatory overhangs, "shrinking to grow profitably"), and a valuation still cheap on the new, higher earnings.
- Manage risk off a durable trend line the stock has "obeyed all year" (e.g. the 200-day) rather than trading the earnings event itself.
Here: Brown's C — up 65% over a year but still −4% annualized over 20 years ("room to run"), Jane Fraser turnaround, Banamex spin + consent-order exit as catalysts, +56% EPS; risk managed off the 110–115 200-day, "don't use earnings as the catalyst."
Watch for
- A lagging sector turning; a turnaround with catalysts still pending; a name honoring its 200-day all year as the risk line.
9. Name the enterprise loser — who gets bundled out?
The repeatable method
- In a murky layer where winners are hard to pick, invert the question and identify the clearer losers — a discipline that's often easier and just as actionable (avoid/short).
- Flag any standalone product whose "good enough" substitute comes bundled free inside a platform customers already pay for — that's structural pricing pressure, not a fixable execution gap.
- Separately, dock a giant spender whose flagship AI product is mediocre and whose spend shows "no output" — execution risk on top of the CapEx discount.
Here: Talkington — "ZM should not exist as a public company" at ~$28B because Teams is bundled; and she owns but doubts MSFT's execution (Copilot "more like Teams," "I just don't see the output"). "Easier to think through who are the losers, not the winners."
Watch for
- A point product duplicated free inside a dominant suite; a heavy AI spender whose own product underwhelms — both flags for the loser side.
Methods distilled from the public CNBC Halftime Report audio episode (transcript in transcript.txt) for personal study. Not investment advice. © CNBC for source material.